Lindbrook Capital, LLC Precigen, Inc. Transaction History

Lindbrook Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$1.27 - $1.75 $340 - $469	268 Added 16.32%	1,910 $3,000
Q4 2023 Jan 31, 2024	BUY	$0.89 - $1.41 $1,461 - $2,315	1,642 New	1,642 $2,000
Q4 2022 Jan 24, 2023	SELL	$1.27 - $2.26 $2,249 - $4,002	-1,771 Closed	0 $0
Q3 2022 Nov 10, 2022	BUY	$1.41 - $2.79 $1,144 - $2,265	812 Added 84.67%	1,771 $4,000
Q2 2022 Aug 01, 2022	BUY	$1.15 - $2.53 $1,102 - $2,426	959 New	959 $1,000
Q1 2022 Apr 21, 2022	SELL	$1.91 - $3.98 $1,440 - $3,000	-754 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$3.53 - $5.5 $762 - $1,188	216 Added 40.15%	754 $3,000
Q1 2021 Apr 28, 2021	SELL	$6.74 - $10.95 $674 - $1,095	-100 Reduced 15.67%	538 $4,000
Q4 2020 Jan 27, 2021	BUY	$3.75 - $10.56 $375 - $1,056	100 Added 18.59%	638 $7,000
Q2 2020 Jul 27, 2020	BUY	$2.16 - $5.46 $1,162 - $2,937	538 New	538 $3,000

141

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $271M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.